GARS1 and Charcot-Marie-Tooth disease: However, given the differences between human and rodent nervous systems, a change in localization of mutant GARS in the CNS or peripheral neurons of human CMT patients, e.g., in nuclei, mitochondria, or cytosolic granules, cannot be formally excluded (Fig 2, mechanism f,g,h).